These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6383334)

  • 1. Demonstration of lysozyme in primary ovarian tumors using the immunoperoxidase technique.
    Cazzola P; Lo Re V; Matturri L; Tedeschi D
    Basic Appl Histochem; 1984; 28(2):169-76. PubMed ID: 6383334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amylase in fallopian tube and serous ovarian neoplasms: immunohistochemical localization.
    Bruns DE; Mills SE; Savory J
    Arch Pathol Lab Med; 1982 Jan; 106(1):17-20. PubMed ID: 6172088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients.
    Devaney K; Goodman ZD; Ishak KG
    Am J Surg Pathol; 1994 Nov; 18(11):1078-91. PubMed ID: 7943529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunolocalization of alpha-amylase in ovarian mucinous tumours.
    Griffin NR; Wells M
    Int J Gynecol Pathol; 1990; 9(1):41-6. PubMed ID: 2294062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum 72 KDa metalloproteinase in serous ovarian tumors: comparison with CA 125.
    Garzetti GG; Ciavattini A; Lucarini G; Goteri G; Romanini C; Biagini G
    Anticancer Res; 1996; 16(4A):2123-7. PubMed ID: 8712754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Histopathology of the ovarian tumors derived from the Müllerian (paramesonephric) epithelium and their differential diagnosis. I. Adenofibroma. Serous and mucinous cystadenomas and cystadenocarcinomas (author's transl)].
    Jirásek JE
    Cesk Gynekol; 1973 Nov; 38(9):705-8. PubMed ID: 4765179
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors.
    Huang LW; Garrett AP; Bell DA; Welch WR; Berkowitz RS; Mok SC
    Gynecol Oncol; 2000 Jun; 77(3):369-76. PubMed ID: 10831344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and tissue measurements of CA72-4 in ovarian cancer patients.
    Negishi Y; Iwabuchi H; Sakunaga H; Sakamoto M; Okabe K; Sato H; Asano G
    Gynecol Oncol; 1993 Feb; 48(2):148-54. PubMed ID: 8381375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Muramidase activity in the fluid content of ovarian cysts].
    Kovanyi G; Holzner H
    Wien Klin Wochenschr; 1970 May; 82(20):375-8. PubMed ID: 5524224
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sharing antigenic determinant of colon carcinoma between serous and mucinous tumors of the ovary].
    Liu MP; Lu ZT; Chen W
    Zhonghua Fu Chan Ke Za Zhi; 1994 Jul; 29(7):398-400, 444. PubMed ID: 7528120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors, and invasive carcinomas.
    Datar RH; Naritoku WY; Li P; Tsao-Wei D; Groshen S; Taylor CR; Imam SA
    Gynecol Oncol; 1999 Sep; 74(3):338-45. PubMed ID: 10479490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of serous papillary cystadenocarcinoma of the ovary with hyperamylasemia].
    Nakamura S; Hirabayashi N; Asai J
    Gan No Rinsho; 1987 Apr; 33(4):428-33. PubMed ID: 2437341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological significance of DEK overexpression in serous ovarian tumors.
    Han S; Xuan Y; Liu S; Zhang M; Jin D; Jin R; Lin Z
    Pathol Int; 2009 Jul; 59(7):443-7. PubMed ID: 19563407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial ovarian tumors in children: a retrospective analysis.
    Morowitz M; Huff D; von Allmen D
    J Pediatr Surg; 2003 Mar; 38(3):331-5; discussion 331-5. PubMed ID: 12632344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of mRNAs for type I and type III procollagens in serous ovarian cystadenomas and cystadenocarcinomas.
    Kauppila S; Saarela J; Stenbäck F; Risteli J; Kauppila A; Risteli L
    Am J Pathol; 1996 Feb; 148(2):539-48. PubMed ID: 8579116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ human telomerase reverse transcriptase expression pattern in normal and neoplastic ovarian tissues.
    Baykal A; Thompson JA; Xu XC; Hahn WC; Deavers MT; Malpica A; Gershenson DM; Silva EG; Liu J
    Oncol Rep; 2004 Feb; 11(2):297-302. PubMed ID: 14719058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumours.
    Evans MF; McDicken IW; Herrington CS
    J Pathol; 1999 Sep; 189(1):53-9. PubMed ID: 10451488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of ovarian carcinoma: a review of 14 years' experience at Beth Israel Hospital.
    Blinick G; Kabakow B; Antopol W; Wallach RC
    Mt Sinai J Med; 1972; 39(5):447-57. PubMed ID: 4628079
    [No Abstract]   [Full Text] [Related]  

  • 19. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
    McKenney JK; Soslow RA; Longacre TA
    Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucinous tumors of the ovary with argyrophil cells. An immunohistochemical analysis.
    Aguirre P; Scully RE; Dayal Y; DeLellis RA
    Am J Surg Pathol; 1984 May; 8(5):345-56. PubMed ID: 6203413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.